Literature DB >> 24962931

Identification of mitragynine and O-desmethyltramadol in Kratom and legal high products sold online.

Theresa M Scott1, Jillian K Yeakel, Barry K Logan.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2014        PMID： 24962931     DOI： 10.1002/dta.1673

Source DB:  PubMed          Journal:  Drug Test Anal        ISSN： 1942-7603            Impact factor:   3.345


× No keyword cloud information.
  9 in total

Review 1.  The pharmacology and toxicology of kratom: from traditional herb to drug of abuse.

Authors:  Marcus L Warner; Nellie C Kaufman; Oliver Grundmann
Journal:  Int J Legal Med       Date:  2015-10-28       Impact factor: 2.686

Review 2.  The abuse potential of kratom according the 8 factors of the controlled substances act: implications for regulation and research.

Authors:  Jack E Henningfield; Reginald V Fant; Daniel W Wang
Journal:  Psychopharmacology (Berl)       Date:  2017-12-23       Impact factor: 4.530

Review 3.  Non-Medical Use of Novel Synthetic Opioids: A New Challenge to Public Health.

Authors:  Barbara Lovrecic; Mercedes Lovrecic; Branko Gabrovec; Marco Carli; Matteo Pacini; Angelo G I Maremmani; Icro Maremmani
Journal:  Int J Environ Res Public Health       Date:  2019-01-09       Impact factor: 3.390

4.  Kratom policy: The challenge of balancing therapeutic potential with public safety.

Authors:  Walter C Prozialeck; Bonnie A Avery; Edward W Boyer; Oliver Grundmann; Jack E Henningfield; Andrew C Kruegel; Lance R McMahon; Christopher R McCurdy; Marc T Swogger; Charles A Veltri; Darshan Singh
Journal:  Int J Drug Policy       Date:  2019-05-16

Review 5.  Understanding Kratom Use: A Guide for Healthcare Providers.

Authors:  Marc T Swogger; Kirsten E Smith; Albert Garcia-Romeu; Oliver Grundmann; Charles A Veltri; Jack E Henningfield; Lorna Y Busch
Journal:  Front Pharmacol       Date:  2022-03-02       Impact factor: 5.810

Review 6.  Mitragyna Species as Pharmacological Agents: From Abuse to Promising Pharmaceutical Products.

Authors:  Islamudin Ahmad; Wisnu Cahyo Prabowo; Muhammad Arifuddin; Jaka Fadraersada; Niken Indriyanti; Herman Herman; Reza Yuridian Purwoko; Firzan Nainu; Anton Rahmadi; Swandari Paramita; Hadi Kuncoro; Nur Mita; Angga Cipta Narsa; Fajar Prasetya; Arsyik Ibrahim; Laode Rijai; Gemini Alam; Abdul Mun'im; Sukanya Dej-Adisai
Journal:  Life (Basel)       Date:  2022-01-27

7.  Public Health Implications and Possible Sources of Lead (Pb) as a Contaminant of Poorly Regulated Kratom Products in the United States.

Authors:  Walter Prozialeck; Alexandra Fowler; Joshua Edwards
Journal:  Toxics       Date:  2022-07-19

8.  Suspected Adulteration of Commercial Kratom Products with 7-Hydroxymitragynine.

Authors:  Alicia G Lydecker; Abhisheak Sharma; Christopher R McCurdy; Bonnie A Avery; Kavita M Babu; Edward W Boyer
Journal:  J Med Toxicol       Date:  2016-10-17

Review 9.  Following "the Roots" of Kratom (Mitragyna speciosa): The Evolution of an Enhancer from a Traditional Use to Increase Work and Productivity in Southeast Asia to a Recreational Psychoactive Drug in Western Countries.

Authors:  Eduardo Cinosi; Giovanni Martinotti; Pierluigi Simonato; Darshan Singh; Zsolt Demetrovics; Andres Roman-Urrestarazu; Francesco Saverio Bersani; Balasingam Vicknasingam; Giulia Piazzon; Jih-Heng Li; Wen-Jing Yu; Máté Kapitány-Fövény; Judit Farkas; Massimo Di Giannantonio; Ornella Corazza
Journal:  Biomed Res Int       Date:  2015-11-10       Impact factor: 3.411
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.